研究文章
血清细胞因子水平及其与自身免疫性肝病患者的临床特征
|
|
AILD () |
AIH () |
重叠综合征() |
|
|
| 年龄、年(M±SD) |
48.2±15.1 |
43.2±15.5 |
53.9±12.6 |
|
| 性别,女性(%) |
54 (90%) |
28 (87.5%) |
26 (92.8%) |
|
| 症状持续时间、年(M±SD) |
5.9±5.6 |
6.9±6.3 |
4.7±4.5 |
|
| 黄疸(%) |
36 (60%) |
17 (53.1%) |
19 (67.9%) |
|
| 腹部不适(%) |
34 (56.7%) |
16 (50%) |
18 (64.3%) |
|
| 肝外的迹象(%) |
41 (68.3%) |
23 (71.9%) |
17 (60.7%) |
|
| 肝硬化(%) |
43 (71.7%) |
23 (71.9%) |
20 (71.4%) |
|
| 血红蛋白、g / L (M±SD) |
120.9±15.1 |
118.1±20.2 |
124.2±18.3 |
|
| ESR, mm / h (M±SD) |
24.7±14.9 |
17.3±12.1 |
33.12±13.3 |
|
| ALT, U / L (M±SD) |
107.6±143.1 |
68.8±72.8 |
147.8±183.6 |
|
| AST, U / L (M±SD) |
84.4±68.0 |
72.9±68.4 |
96.7±66.6 |
|
| 碱性磷酸酶,U / L (M±SD) |
220.4±68.0 |
107.7±71.4 |
337.8±176.9 |
|
| GGT, U / L (M±SD) |
258.9±296.1 |
134.3±135.8 |
389.1±359.9 |
|
| 总胆红素,μmol / L (M±SD) |
58.9±100.5 |
59.6±91.47 |
58.2±111.0 |
|
| 免疫球蛋白,毫克/毫升(M±SD) |
18.2±5.3 |
18.6±5.6 |
17.8±4.8 |
|
| 循环免疫复合物,U / L (M±SD) |
241.1±165.3 |
205.2±133.6 |
283.5±190.8 |
|
| 白蛋白,g / L (M±SD) |
48.3±5.3 |
47.9±5.9 |
48.9±4.3 |
|
| 丙种球蛋白,g / L (M±SD) |
24.9±5.7 |
26.1±6.2 |
23.2±4.5 |
|
| UDCA摄入量(%) |
52 (86.7%) |
25 (78.1%) |
27 (96.4%) |
|
| GC的摄入量(%) |
20 (33.3%) |
25 (78.1%) |
15 (53.6%) |
|
| GC剂量,毫克/天(M±SD) |
17.0±11.8 |
26.1±6.2 |
17.8±15.5 |
|
| 阿扎摄入量(%) |
6 (10%) |
5 (15.6%) |
1 (3.6%) |
|
|
|
AILD:自身免疫性肝病;AIH:自身免疫性肝炎;ESR:红细胞沉降率;ALT:丙氨酸转氨酶;AST:天冬氨酸转氨酶;GGT: gamma-glutamyl转肽酶;UDCA:熊去氧胆酸;GC:糖皮质激素;阿扎:咪唑硫嘌呤。
|
